Evidence map›Paper›PMID 16537301›Full record

ArticleWomen & health2005

High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.

Katie E Mosack, Margaret R Weeks, Laurie Novick Sylla, Maryann Abbott

Open access · greenAbstract readControlled Clinical Trial
In one paragraph

Article in Women & health, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Predictors of using a microbicide-like product among adolescent girls.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Katie E MosackCenter for AIDS Intervention Research, Medical College of Wisconsin, 2071 N Summit Ave, Milwaukee, WI, 53202, USA. kmosack@mcw.edu
Margaret R Weeks
Laurie Novick Sylla
Maryann Abbott
Institute For Community Research · USAIDS United · USMedical College of Wisconsin · US

Funding

QUANTITATIVE COREP30MH052776 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI GALLETLY, CAROL L · 1994 to 2018
$33.2M
NRSA POSTDOCTORAL TRAINING PROGRAM IN HIV PREVENTION REST32MH019985 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI GALLETLY, CAROL L · 1996 to 2017
$2.4M
Microbicide Acceptance--Prevent HIV in High-Risk WomenR01MH063631 · NIMH · INSTITUTE FOR COMMUNITY RESEARCH · PI WEEKS, MARGARET R · 2000 to 2002
$1.3M
LONGITUDINAL STUDY OF AIDS RISK AMONG DRUG USERSR01DA011359 · NIDA · HISPANIC HEALTH COUNCIL · PI SINGER, MERRILL C · 1998 to 2000
$524k
NIDA NIH HHS R01-DA11359-02S1NIMH NIH HHS P30 MH052776NIMH NIH HHS P30-MH52776NIMH NIH HHS R01 MH063631NIMH NIH HHS T32 MH019985NIMH NIH HHS T32-MH19985
6 · The paper itself

Abstract

Vaginal microbicides could provide an important option for women in the prevention of HIV and other STIs. Researchers have examined women's preferences for specific product characteristics; however, much remains to be learned about women's willingness to use them with a variety of partners. This study examined high-risk women's experiences using simulated microbicides during a two-week trial. Ninety-six women completed the trial by using the product and reporting their experiences with different partner types. Analyses were conducted to examine differences between women who always used the product and those who used it less than all the time and whether risk and relationship attitudes were associated with simulated microbicide use during participants' most recent sexual encounters. All participants used the product and on an average of 79-94% of sexual encounters. The majority of the participants reported liking the simulated product. Women indicated that they would want to use microbicides in order to feel in control of their health, to avoid having to ask their partner, and because microbicides would be easier to use than condoms. Women who used the product 100% of the time had less relationship power; however, greater sexual assertiveness for STI prevention predicted simulated microbicide use during the most recent sexual encounter, and interventions may need to focus on promoting sexual assertiveness for disease prevention.

Indexed as

Health Knowledge, Attitudes, PracticeAdministration, IntravaginalAdultAnti-Bacterial AgentsAnti-HIV AgentsConnecticutFemaleHumansPatient Acceptance of Health CarePilot ProjectsSexually Transmitted DiseasesSurveys and QuestionnairesVaginaVaginal Creams, Foams, and JelliesWomen's HealthAnti-Bacterial AgentsAnti-HIV AgentsVaginal Creams, Foams, and Jellies

Identifiers

PMID16537301
PMCPMC2919063
OpenAlexW2063495093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.